Claritev Corp

News & Events zu Claritev Corp (CTEV)

$23.500

0.000 (0.00%)Zum Schluss

CTEV-News

CTEV-Events

9/22 09:30

Claritev Selected to Support World Trade Center Health Program

Claritev Corporation has been selected by General Dynamics Information Technology to support the World Trade Center Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010. It provides nationwide medical monitoring and treatment to responders and survivors of the events of September 11, 2001. As part of GDIT's team, Claritev will leverage its existing provider network to administer the Nationwide Provider Network, ensuring members across the country have access to available, high-quality healthcare. Claritev's extensive network will connect Survivors and Responders who reside outside of the New York metropolitan area with healthcare providers experienced in diagnosing and treating unique conditions related to 9/11 exposures.

9/15 09:30

Claritev Appoints Ben Letham as Director

Claritev (CTEV) announced that its Board of Directors has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham currently serves as a research scientist at Meta (META).

8/7 05:30

Company Raises FY26 Adjusted EBITDA Outlook to $620M

Consensus $993.39M. Raises FY26 adjusted EBITDA view to $620M-$620M from $605M-$615M. Backs FY26 capital expenditures view $160M-$170M. Dalton added, "This success is most clearly reflected in our bookings which were spread across solutions and verticals, with notable strength in the TPA market where we closed several seven-figure transactions. With more than $70 million in bookings through the first half of 2026, we are well on our way to achieving our full year target of $100 million which would represent 50% growth over 2025 and is a leading indicator of continued growth in 2027 and beyond."

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln